Primary |
Fluid Retention |
11.5% |
Cardiac Failure Congestive |
10.8% |
Oedema |
10.1% |
Pulmonary Arterial Hypertension |
9.4% |
Diuretic Therapy |
8.6% |
Cardiac Failure Chronic |
7.9% |
Type 2 Diabetes Mellitus |
7.2% |
Hypertension |
6.5% |
Cardiac Failure |
5.0% |
Cardiac Disorder |
2.9% |
Renal Disorder |
2.9% |
Renal Failure Chronic |
2.9% |
Generalised Oedema |
2.2% |
Oedema Peripheral |
2.2% |
Rheumatoid Arthritis |
2.2% |
Thrombosis Prophylaxis |
2.2% |
Cardiovascular Disorder |
1.4% |
Chronic Obstructive Pulmonary Disease |
1.4% |
Polyuria |
1.4% |
Upper Respiratory Tract Infection |
1.4% |
|
Renal Failure Acute |
20.6% |
Vomiting |
9.5% |
Hypokalaemia |
7.9% |
Hypotension |
7.9% |
Renal Failure Chronic |
6.3% |
Renal Failure |
4.8% |
Weight Decreased |
4.8% |
Blood Potassium Decreased |
3.2% |
Disease Progression |
3.2% |
Muscle Spasms |
3.2% |
Nausea |
3.2% |
Pancreatitis |
3.2% |
Pancreatitis Acute |
3.2% |
Pulmonary Congestion |
3.2% |
Renal Impairment |
3.2% |
Syncope |
3.2% |
Torsade De Pointes |
3.2% |
Wrong Drug Administered |
3.2% |
Agranulocytosis |
1.6% |
Anaemia |
1.6% |
|
Secondary |
Product Used For Unknown Indication |
38.7% |
Drug Use For Unknown Indication |
12.8% |
Hypertension |
5.9% |
Cardiac Failure Congestive |
5.8% |
Cardiac Failure |
5.1% |
Type 2 Diabetes Mellitus |
3.7% |
Cardiac Failure Chronic |
3.5% |
Pain |
2.9% |
Diabetes Mellitus |
2.8% |
Pulmonary Arterial Hypertension |
2.8% |
Angina Pectoris |
2.3% |
Sepsis |
2.2% |
Diuretic Therapy |
2.0% |
Depression |
1.9% |
Atrial Fibrillation |
1.4% |
Renal Failure Acute |
1.3% |
Chronic Obstructive Pulmonary Disease |
1.2% |
Oedema |
1.2% |
Prophylaxis |
1.1% |
Coronary Artery Disease |
1.1% |
|
Renal Failure Acute |
20.3% |
Toxicity To Various Agents |
8.9% |
Vomiting |
7.6% |
Hypokalaemia |
7.0% |
Death |
6.3% |
Tremor |
5.1% |
Confusional State |
3.8% |
Medication Error |
3.8% |
Poisoning |
3.8% |
Syncope |
3.8% |
Allergic Myocarditis |
3.2% |
Cardio-respiratory Arrest |
3.2% |
Nausea |
3.2% |
Respiratory Arrest |
3.2% |
Somnolence |
3.2% |
Torsade De Pointes |
3.2% |
Urticaria |
3.2% |
Azotaemia |
2.5% |
Dizziness |
2.5% |
Hypotension |
2.5% |
|
Concomitant |
Product Used For Unknown Indication |
35.7% |
Drug Use For Unknown Indication |
21.4% |
Pulmonary Arterial Hypertension |
6.0% |
Hypertension |
5.4% |
Atrial Fibrillation |
3.9% |
Pain |
3.4% |
Diabetes Mellitus |
2.9% |
Cardiac Failure Congestive |
2.2% |
Type 2 Diabetes Mellitus |
2.2% |
Pulmonary Hypertension |
2.1% |
Cardiac Disorder |
2.0% |
Chronic Obstructive Pulmonary Disease |
1.8% |
Multiple Myeloma |
1.6% |
Blood Cholesterol Increased |
1.5% |
Depression |
1.4% |
Nuclear Magnetic Resonance Imaging |
1.4% |
Fluid Retention |
1.3% |
Gout |
1.3% |
Diuretic Therapy |
1.3% |
Prophylaxis |
1.2% |
|
Vomiting |
13.9% |
Weight Increased |
10.9% |
Death |
10.4% |
Weight Decreased |
9.7% |
Renal Failure Acute |
5.7% |
Renal Failure |
5.0% |
Ventricular Tachycardia |
4.3% |
Wheezing |
4.2% |
Thrombocytopenia |
3.5% |
Cardiac Failure Congestive |
3.3% |
Respiratory Failure |
3.3% |
Urinary Tract Infection |
3.3% |
Blood Glucose Increased |
2.9% |
Syncope |
2.9% |
Wound Infection |
2.9% |
Pneumonia |
2.8% |
Therapeutic Agent Toxicity |
2.8% |
Unevaluable Event |
2.8% |
Vision Blurred |
2.6% |
Pain |
2.5% |
|
Interacting |
Product Used For Unknown Indication |
45.0% |
Drug Use For Unknown Indication |
18.8% |
Pain |
15.0% |
Essential Hypertension |
12.5% |
Atrial Fibrillation |
3.8% |
Cardiac Disorder |
1.3% |
Depression |
1.3% |
Nephrogenic Anaemia |
1.3% |
Renal Failure Chronic |
1.3% |
|
Confusional State |
13.3% |
Dehydration |
13.3% |
Delirium |
6.7% |
Diarrhoea |
6.7% |
Disorientation |
6.7% |
Drug Interaction |
6.7% |
Hypokalaemia |
6.7% |
Hyponatraemia |
6.7% |
Nasal Disorder |
6.7% |
Sinus Bradycardia |
6.7% |
Stupor |
6.7% |
Syncope |
6.7% |
Visual Impairment |
6.7% |
|